INDOCO REMEDIES LTD.

NSE : INDOCOBSE : 532612ISIN CODE : INE873D01024Industry : Pharmaceuticals & DrugsHouse : Private
BSE329.004.05 (+1.25 %)
PREV CLOSE ( ) 324.95
OPEN PRICE ( ) 332.20
BID PRICE (QTY) 328.10 (40)
OFFER PRICE (QTY) 328.95 (32)
VOLUME 4364
TODAY'S LOW / HIGH ( )325.25 332.20
52 WK LOW / HIGH ( )307 416.95
NSE328.254.2 (+1.3 %)
PREV CLOSE( ) 324.05
OPEN PRICE ( ) 325.70
BID PRICE (QTY) 328.25 (15)
OFFER PRICE (QTY) 328.45 (87)
VOLUME 33199
TODAY'S LOW / HIGH( ) 325.10 329.95
52 WK LOW / HIGH ( )306.4 415

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.